Dietressa, tablets, 100 pcs.

Pharmacological properties

Pharmacodynamics

Through allosteric modulation mechanisms the drug sensitizes cannabinoid receptor type I, which is accompanied by increase of its
sensitivity to endogenous cannabinoid neuropeptides. This results in normalization of the endocannabinoid regulation of the mesolimbic system including the food center in the hypothalamus.

It was shown experimentally that when the drug is given to animals the self-stimulation of the lateral hypothalamus is abolished, which indicates saturation of the system of positive emotional reinforcement, reduction of euphoric importance of food, weight gain reduction under high fat diet.

Administration of the drug is accompanied by an inhibitory effect on the processes of obesity: a decrease in food intake and weight loss, without causing both inhibitory and stimulating effects on higher nervous activity.The effect of weight reduction is caused not only by the central, but also by peripheral mechanisms – due to modulation of cannabinoid receptors of adipocytes (fat cells), activation of their basic metabolism.

The drug is not addictive and does not have narcotic effect.

Pharmacokinetics

The sensitivity of modern physico-chemical methods of analysis (gas-liquid chromatography, high performance liquid chromatography,
Chromato-mass spectrometry) does not allow evaluating the content of ultra-low doses of antibodies in biological fluids, organs and tissues, which makes it technically impossible to study the pharmacokinetics of the drug.

Indications

Active ingredient

Composition

How to take, the dosage

Interaction

Special Instructions

Synopsis

Contraindications

Side effects

Overdose

Pregnancy use

Similarities